Clinical Cancer Research.American Association for Cancer Research, 2017 August; Lowenfeld et al. Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route:  Results of Randomized Selection Design Trial

BMC Cancer 2013, 13:512, www.biomedcentral.com/1471-2407/13/512. Zhou et al.  Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis:  a population-based cohort study

Journal of Clinical Oncology, 2012 April; Number 12, Vol. 20; 1268-1273. Allred, et al. Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

J Immunother . 2012 January ; 35(1): 54–65. oi:10.1097/CJI.0b013e318235f51: Koski, et al.  “A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer”